openPR Logo
Press release

Asia-Pacific Influenza Market estimated to reach $2.18 billion by 2021 with a CAGR of 10.70%

07-05-2017 07:46 AM CET | Health & Medicine

Press release from: Market Data Forecast

Market data forecast

Market data forecast

The Asia-Pacific ‘Influenza Market' research report, published by Market Data Forecast estimates that the market itself was worth $1.31 billion in 2016 and expected to grow at a CAGR of 10.70%, to reach $2.18 billion by 2021.

Influenza, or flu, is a respiratory illness caused by a virus. Flu is highly contagious and is normally spread by the coughs and sneezes of an infected person.

You can also catch flu by touching an infected person, for instance, shaking hands. Adults are contagious 1-2 days before getting symptoms and up to 7 days after becoming ill. This means that you can spread the influenza virus before you even know you are infected.

Request Sample : http://www.marketdataforecast.com/market-reports/asia-pacific-influenza-market-1707/request-sample

Over 200,000 people are hospitalized from flu complications each year, and about 36,000 people are estimated to die as a result of flu. It is estimated that 250,000-500,000 people die each year as a result of flu. In industrialized countries, the majority of deaths occur among people over the age of 65.
A flu epidemic - where a large number of people in one country are infected - can last several weeks.

Customize the report: http://www.marketdataforecast.com/market-reports/asia-pacific-influenza-market-1707/customize-report

The report also presents detailed analysis of multitude of factors affecting the Influenza market bearing either positive or negative outcomes. Some of those factors are:

• Rising public awareness
• Boost in healthcare expenditure
• Cost-effectiveness of immunization
• Introduction of new medicines
• Increasing government initiatives for vaccination against influenza viruses
• A large section of population, in Asia-Pacific not being immunized against influenza virus, thereby fueling the demand for the product
• Antigenic shift of influenza virus
• Lack of cold storage facility
• Side-effects of product (soreness, allergic reactions, swelling, and redness)
• Remote areas with limited accessibility.

Inquire Before Buying: http://www.marketdataforecast.com/market-reports/asia-pacific-influenza-market-1707/inquire

For granular level understanding the Influenza Market is segmented based on product and application, each being provided with Market Size Estimates and Y-o-Y Forecasts. Asia-Pacific Influenza Market is segmented on the basis of Product Type and Consumer. Based on Product Type, the market is classified into vaccines and drugs. On the basis of Consumer, the market is classified into Children and Adults.

Buy now: http://www.marketdataforecast.com/cart/buy-now/asia-pacific-influenza-market-1707

On the basis of geography, the Asia-pacific Influenza market is segmented into the countries China, India, Japan, and South Korea. The Influenza market in Asia-Pacific is growing fast due to the increasing awareness regarding healthcare.

Request Discount: http://www.marketdataforecast.com/market-reports/asia-pacific-influenza-market-1707/request-discount

The major companies dominating Asia-Pacific Influenza Market are Sanofi-Pasteur (U.S.), AstraZeneca (United Kingdom), F. Hoffmann-La Roche (Switzerland), Novartis (Switzerland), GlaxoSmithKline (U.K.), Pfizer Inc. (U.S.), Merck & Co. (U.S.), Abbott Laboratories (U.S.), Mitsubishi Tanabe Pharma Corporation (Japan), CSL Limited (Australia).

Checkout other related studies in the Pharmaceuticals Segment:

Anti-fungal drugs Market: http://www.marketdataforecast.com/market-reports/global-anti-fungal-drugs-market-242/

Antivenom Market: http://www.marketdataforecast.com/market-reports/global-antivenom-market-1580/

The Asia-Pacific Influenza Market report offers wide-range of scope:
• Regional and country-level analysis that provides an individual perspective of Asia-Pacific region and the aforementioned countries
• Know more about key areas of industry growth via detailed Segment-level analysis on basis of product type long with market size forecasts and y-o-y estimations
• Detailed explanation of major drivers, restraints, opportunities, and challenges(DROC) that affect the market and impact the ever-shifting market dynamics
• Strategic Analyses containing PESTLE and Porter’s Five Forces Analyses which are obtained by studying the macro & micro environmental factors that affect the market demographics
• Comprehensive listing of key market players along with Company overview, product portfolios, financials (subjected to availability), SWOT analysis and analyst overview
• Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
• Market Outlook - Investment opportunities devised by stand in experts to provide both individuals and organizations a strong financial foothold in the market

About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more info kindly visit, www.marketdataforecast.com

Contact:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail:abhishek@marketdataforecast.com
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Asia-Pacific Influenza Market estimated to reach $2.18 billion by 2021 with a CAGR of 10.70% here

News-ID: 608862 • Views:

More Releases from Market Data Forecast

Personalized Nutrition Market is growing at a brisk pace
Personalized Nutrition Market is growing at a brisk pace
The global personalized nutrition market size is expected to be valued at USD 10.84 thousand units in 2024 and reach USD 21.80 thousand units by 2029, growing at a CAGR of 15.0% from 2024 to 2029. Global Personalized Nutrition Market Report Scope: • Market Size (2029): USD 21.80 thousand units • Market Size (2024): USD 10.84 thousand units • CAGR (2024 to 2029): 15% • Base Year: 2023 • Forecast Period: 2024 to 2029 • Segments
Anticipating the Future of the Antibodies Market
Anticipating the Future of the Antibodies Market
The Antibodies market size is expected to be valued at USD 183.7 billion in 2024 and reach USD 183.7 billion by 2029, growing at a CAGR of 11.31% from 2024 to 2029. Antibodies, also known as immunoglobulins, are Y-shaped proteins the immune system produces in response to foreign substances called antigens. Antibodies are employed in various applications, such as diagnostics, research, and therapeutics, which play a crucial role. Global Antibodies Market Report
The Power of Herbal Medicine in Healthcare Market
The Power of Herbal Medicine in Healthcare Market
The herbal medicine market size is expected to be valued at USD 215.4 billion in 2024 and reach USD USD 305.3 billion by 2029, growing at a CAGR of 7.22% from 2024 to 2029. Herbal medicines, derived from plants or plant parts like leaves, flowers, seeds, roots, and stems, have been utilized across diverse cultures for centuries due to their therapeutic properties. They can be prepared in various forms, such as
Innovative Surge Wearable Medical Devices Market Thrives
Innovative Surge Wearable Medical Devices Market Thrives
The global wearable medical devices market size is expected to be valued at USD 11194 million in 2024 and reach USD 28322 million by 2029, growing at a CAGR of 20.40 % from 2024 to 2029. Wearable medical devices are devices that customers can wear, such as activity trackers and smartwatches. These devices are designed to monitor and collect real-time data on customer health and fitness. Global Wearable Medical Devices Market

All 5 Releases


More Releases for Influenza

H1N1 Influenza (Swine Influenza) Market to Witness Growth by 2032, Estimates Del …
DelveInsight's "H1N1 Influenza (Swine Influenza) Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of H1N1 Influenza (Swine Influenza), historical and forecasted epidemiology as well as the H1N1 Influenza (Swine Influenza) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The H1N1 Influenza (Swine Influenza) market report provides current treatment practices, emerging drugs, the market share of the individual therapies,
Influenza Vaccine Market | DPIResearch.com
According to the DPI Research new growth forecast report titled “Worldwide Influenza Vaccines Market Size | Forecast to 2027” to Witness Comprehensive Growth by 2027 DPI Research published a new report on Worldwide Influenza Vaccines Market. The research offers an extensive analysis of key players active in the Worldwide Influenza Vaccines Market. Detailed analysis on operating business segments, product portfolio, business performance, and key strategic developments is offered in the research.
Influenza Vaccines
Influenza Drugs and Vaccines Market describes its growth, size, share, Forecast and trends to 2025 Influenza Drugs and Vaccines Market Production and Demand Analysis 2019 to 2025 Influenza Drugs and Vaccines Market 2019 Manufacturing Analysis and Development Forecast 2025 Influenza Drugs and Vaccines Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025 Influenza Drugs and Vaccines Market to Insight By 2025: Top Key Vendors Influenza Drugs and Vaccines Market Insights 2019, Global and
The Marketed Demand Of Influenza Vaccine Due To Influenza Disease In European Ma …
Europe Influenza Market Influenza is an upper respiratory tract disease and is caused by the influenza virus. Influenza virus is mainly three types namely Influenza A, Influenza B, and Influenza C. Influenza is a communicable disease, spread through a flu cough, droplets from the infected people, sneeze or talks. Influenza commonly occurs in geriatric population and children less than five years of age. The infection may be confirmed by testing
The Marketed Demand Of Influenza Vaccine Due To Influenza Disease In U.S. Market
Influenza is an upper respiratory tract disease and is caused by the Influenza virus. Influenza virus is mainly three types namely Influenza A, Influenza B, and Influenza C. Influenza is a communicable disease, spread through a flu cough, droplets from the infected people, sneeze or talks. Influenza commonly occurs in geriatric population and children with less than 5 years of age. The infection may be confirmed by testing the
Influenza Diagnostics Market
Influenza, commonly known as flu, is an infectious disease caused by the influenza virus. Three varieties of this virus affect people: type A, type B, and type C. Influenza spreads through infectious respiratory secretions caused by aerosol formation due to direct contact with an infected person. This virus can cause seasonal epidemics with high levels of morbidity and mortality. According to WHO, these epidemics were estimated to result in about